Novo Nordisk A/S (NYSE:NVO)
| 91.00 Delayed Data As of Sep 29 |  -0.52 / -0.57%Today’s Change | 49.79 Today|||52-Week Range 100.88 | +34.48% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 2.5B | 2.7B | 3.0B | 2.4B | |
| Short Term Investment Cash | 321.6M | 387.1M | -197.6M | -307.2M | ||
| Cash & Short Term Investments | 3.0B | 3.0B | 3.4B | 2.4B | ||
| Receivables | Receivables | 3.0B | 3.4B | 3.4B | 3.6B | |
| Inventories | Inventories | 1.9B | 2.0B | 2.5B | 2.5B | |
| Current Assets | Prepaid Expenses | 127.9M | -- | -- | -- | |
| Other Current Assets | 0.00 | 0.00 | 391.6M | 504.6M | ||
| Current Assets | 8.0B | 8.5B | 9.7B | 9.0B | ||
| Total Assets | Property, Plant and Equipment - Gross | 7.4B | 8.2B | 10.4B | 11.1B | |
| Depreciation | -3.7B | -3.9B | -4.7B | -4.7B | ||
| Intangible Assets | 314.1M | 385.0M | 536.3M | 788.1M | ||
| Other Assets | 314.1M | 385.0M | 536.3M | 788.1M | ||
| Total Assets | 13.4B | 13.8B | 16.5B | 17.0B | ||
| Liabilities | Accounts Payable | 717.2M | 852.7M | 904.8M | 1.0B | |
| Short Term Debt | 156.2M | 32.5M | 273.2M | 78.9M | ||
| Accrued Expenses | 850.1M | 986.3M | 48.4M | 49.2M | ||
| Other Current Liabilities | 3.9B | 4.6B | 4.8B | 5.5B | ||
| Other Liabilities | 5.9B | 6.7B | 7.6B | 8.3B | ||
| Total Liabilities | Deferred Taxes | -989.8M | -378.7M | -176.6M | -425.1M | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Total Liabilities | 6.5B | 7.4B | 8.5B | 9.0B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 6.8B | 6.4B | 8.0B | 7.9B | ||
| Total Shareholder Equity | 6.8B | 6.4B | 8.0B | 7.9B | ||
| Share Information | Common Shares Outstanding | 2.0B | 2.0B | 1.9B | 1.9B | |
| Addtl. Info. | No data currently available for this section. | |||||